1. Drug development: Pathway for approving antibacterial and antifungal drugs for patients with limited treatment options is infrequently used : report to congressional committees Publication: Washington, DC : United States Government Accountability Office, November 2021 Subject(s): Drug Development -- legislation & jurisprudenceDrug ResistanceGovernment RegulationLegislation, Drug -- organization & administrationUnited StatesUnited States. Food and Drug Administration
